1. Home
  2. KNSA

as 07-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404.

Founded: 2015 Country:
Bermuda
Bermuda
Employees: N/A City: HAMILTON
Market Cap: 1.4B IPO Year: 2018
Target Price: $30.20 AVG Volume (30 days): 521.2K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.12 EPS Growth: -95.65
52 Week Low/High: $13.91 - $22.12 Next Earning Date: 07-23-2024
Revenue: $301,772,000 Revenue Growth: 27.69%
Revenue Growth (this year): 47.27% Revenue Growth (next year): 37.65%

KNSA Daily Stock ML Predictions

Stock Insider Trading Activity of Kiniksa Pharmaceuticals Ltd. (KNSA)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Patel Sanj K KNSA CHAIRMAN & CEO Mar 7 '24 Sell $21.02 65,012 $1,366,552.24 0 SEC Form 4
Patel Sanj K KNSA CHAIRMAN & CEO Mar 4 '24 Sell $21.31 9,406 $200,441.86 73,930 SEC Form 4
Patel Sanj K KNSA CHAIRMAN & CEO Mar 4 '24 Sell $22.00 3,336 $73,392.00 70,594 SEC Form 4
Patel Sanj K KNSA CHAIRMAN & CEO Mar 4 '24 Sell $21.00 5,582 $117,222.00 65,012 SEC Form 4
Paolini John F. KNSA CHIEF MEDICAL OFFICER Mar 1 '24 Sell $21.77 18,844 $410,233.88 44,892 SEC Form 4
Tessari Eben KNSA CHIEF OPERATING OFFICER Mar 1 '24 Sell $22.03 1,189 $26,193.67 122,847 SEC Form 4
Megna Michael R KNSA CHIEF ACCOUNTING OFFICER Feb 28 '24 Sell $21.79 5,126 $111,695.54 17,588 SEC Form 4
Megna Michael R KNSA CHIEF ACCOUNTING OFFICER Feb 28 '24 Sell $21.45 9,659 $207,185.55 17,588 SEC Form 4
Paolini John F. KNSA CHIEF MEDICAL OFFICER Feb 27 '24 Sell $21.03 10,156 $213,580.68 44,892 SEC Form 4
Ragosa Mark KNSA CHIEF FINANCIAL OFFICER Jan 3 '24 Sell $20.00 12,000 $240,000.00 15,632 SEC Form 4
Megna Michael R KNSA CHIEF ACCOUNTING OFFICER Jan 2 '24 Sell $19.17 16,670 $319,563.90 17,005 SEC Form 4
Megna Michael R KNSA CHIEF ACCOUNTING OFFICER Dec 19 '23 Sell $19.13 9,316 $178,215.08 17,005 SEC Form 4
Paolini John F. KNSA CHIEF MEDICAL OFFICER Dec 7 '23 Sell $17.54 7,380 $129,445.20 66,112 SEC Form 4
Paolini John F. KNSA CHIEF MEDICAL OFFICER Dec 7 '23 Sell $17.64 13,017 $229,619.88 53,095 SEC Form 4
Paolini John F. KNSA CHIEF MEDICAL OFFICER Dec 7 '23 Sell $17.75 6,702 $118,960.50 46,393 SEC Form 4
Paolini John F. KNSA CHIEF MEDICAL OFFICER Dec 7 '23 Sell $17.81 1,501 $26,732.81 44,892 SEC Form 4

Share on Social Networks: